Omnicell (NASDAQ: OMCL) revenue
Omnicell reported revenue of $1,185m for fiscal 2025, 6.5% more than in fiscal 2024 ($1,112m). Since fiscal 2016 its revenue has grown by 70.3%, an average growth of 6.1% a year.
Omnicell's best year of the last 10 was fiscal 2022. The biggest drop was in fiscal 2023, −11.5%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $1,185m | +6.5% | $5.2m | 0.4% |
| 2024 | $1,112m | −3.0% | $0.3m | 0.0% |
| 2023 | $1,147m | −11.5% | −$34.9m | −3.0% |
| 2022 | $1,296m | +14.5% | −$2.3m | −0.2% |
| 2021 | $1,132m | +26.9% | $89.5m | 7.9% |
| 2020 | $892.2m | −0.5% | $35.5m | 4.0% |
| 2019 | $897.0m | +13.9% | $78.4m | 8.7% |
| 2018 | $787.3m | +10.5% | $44.4m | 5.6% |
| 2017 | $712.7m | +2.4% | $11.1m | 1.6% |
| 2016 | $695.9m | — | $21.4m | 3.1% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Omnicell revenue compared with its sector
By revenue for its latest fiscal year, Omnicell ranks 140th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Omnicell, 6.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 138th | Indivior Pharmaceuticals | $1,239m | 4.3% |
| 139th | Bio-Techne | $1,215m | −0.4% |
| 140th | Omnicell | $1,185m | 6.5% |
| 141st | Trulieve Cannabis | $1,181m | −0.4% |
| 142nd | Sotera Health | $1,164m | 5.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Omnicell
- How much revenue did Omnicell make in fiscal 2025?
- Omnicell reported revenue of $1,185m for fiscal 2025, compared with $1,112m in fiscal 2024.
- How much has the revenue of Omnicell grown?
- Between fiscal 2016 and fiscal 2025 it went from $695.9m to $1,185m: 70.3% more, an average growth of 6.1% a year.
- What was the best year for revenue at Omnicell?
- Of its last 10 fiscal years, fiscal 2022, with $1,296m.
- Where does Omnicell rank in its sector by revenue?
- It ranks 140th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Omnicell come from?
- From the annual report (Form 10-K) that Omnicell files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Omnicell files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Omnicell: the Omnicell page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.